LEXINGTON, Mass, June 26, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical […]
Designation offers potential for expedited development and reviewAxsome now granted two Breakthrough Therapy designations for AXS-05 for separate CNS indicationsNEW […]
MALVERN, Pa., June 26, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, […]
RESEARCH TRIANGLE PARK, N.C., June 26, 2020 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company […]